|Articles|October 30, 2018
Biogen and Samsung Bioepis Launch Humira Biosimilar in Europe
Author(s)BioPharm International Editors
The companies announced the European launch of Imraldi (adalimumab), a biosimilar referencing AbbVie’s blockbuster Humira (adalimumab).
Advertisement
Biogen and Samsung Bioepis announced the European launch of Imraldi (adalimumab), a biosimilar referencing AbbVie’s blockbuster biologic, Humira (adalimumab), in an Oct. 17, 2018 press release. AbbVie’s Humira is that company’s top-selling product with